Clinical Trial 18601

Cancer Type: Breast
Interventions:

Study Type: Health Services Research
Phase of Study: Pilot
Investigators:


    Overview

    Study Title

    Educational Intervention to Increase Genetic Counseling Use in Hispanic Breast Cancer Survivors.

    Summary

    The purpose of this study is to review and refine the materials used to raise awareness and use of genetic counseling among Spanish-speaking breast cancer survivors who may have increased risk for having cancer run in their families due to genetics.

    Objective

    Aim 1: Refine and expand an educational intervention (brochure) to increase uptake of GC for Spanish-speaking/preferring high-risk BC survivors. Aim 2: Explore the preliminary efficacy of the educational intervention compared to standard clinical care (factsheet). We hypothesize that women in the intervention group will have higher uptake of GC, greater increases in knowledge, and more perceived benefits related to GC compared to the control group. Aim 3: Explore the feasibility, acceptability, and preliminary impact (e.g., satisfaction, knowledge, distress) of telephone GC services for Spanish-speaking/preferring high-risk BC survivors.

    Inclusion Criteria

  • Female breast cancer patients
  • => 25 years of age
  • Have no documented or observable psychiatric or neurological disorders that would interfere with study participation (e.g., dementia, psychosis)
  • Are capable of speaking and reading standard Spanish
  • Have not attended or scheduled an appointment for genetic counseling (GC) at the time of recruitment
  • Have a mailing address and working telephone number
  • Provide written informed consent
  • Meet >1 of the National Comprehensive Cancer Network personal or family history GC referral criteria: (a) Personal History of: Breast cancer less than or equal to age 50; Bilateral breast cancer; Multiple primary cancers except basal cell carcinoma; Triple negative breast cancer; Ovarian cancer or fallopian tube cancer at any age. (b) Family History of: Two or more relatives diagnosed with breast cancer; A first degree relative diagnosed with breast cancer less than or equal to age 50; Any blood relative diagnosed with ovarian cancer; Two or more relatives on the same side of the family with breast, ovarian, pancreatic, or prostate cancer; and/or any male relatives diagnosed with breast cancer.
  • Phase 2 participants must also have a healthcare provider who can receive copies of test results.